Enrique A Conterno - Net Worth and Insider Trading
Enrique A Conterno Net Worth
The estimated net worth of Enrique A Conterno is at least $101 Million dollars as of 2024-04-26. Enrique A Conterno is the SVP&Pres, LillyDiab & LillyUSA of Eli Lilly and Co and owns about 138,121 shares of Eli Lilly and Co (LLY) stock worth over $100 Million. Enrique A Conterno is also the CEO of FibroGen Inc and owns about 402,522 shares of FibroGen Inc (FGEN) stock worth over $410,572. Details can be seen in Enrique A Conterno's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Enrique A Conterno has not made any transactions after 2023-07-07 and currently still holds the listed stock(s).
Transaction Summary of Enrique A Conterno
Enrique A Conterno Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Enrique A Conterno owns 2 companies in total, including FibroGen Inc (FGEN) , and Eli Lilly and Co (LLY) .
Click here to see the complete history of Enrique A Conterno’s form 4 insider trades.
Insider Ownership Summary of Enrique A Conterno
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FGEN | FibroGen Inc | 2023-07-07 | director & Chief Executive Officer |
| LLY | Eli Lilly and Co | 2019-02-15 | Sr. VP & Pres. & Lilly Diabetes |
Enrique A Conterno Latest Holdings Summary
Enrique A Conterno currently owns a total of 2 stocks. Among these stocks, Enrique A Conterno owns 138,121 shares of Eli Lilly and Co (LLY) as of February 15, 2019, with a value of $100 Million and a weighting of 99.59%. Enrique A Conterno also owns 402,522 shares of FibroGen Inc (FGEN) as of July 7, 2023, with a value of $410,572 and a weighting of 0.41%.
Latest Holdings of Enrique A Conterno
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co | 2019-02-15 | 138,121 | 724.87 | 100,119,769 |
| FGEN | FibroGen Inc | 2023-07-07 | 402,522 | 1.02 | 410,572 |
Holding Weightings of Enrique A Conterno
Enrique A Conterno Form 4 Trading Tracker
According to the SEC Form 4 filings, Enrique A Conterno has made a total of 0 transactions in Eli Lilly and Co (LLY) over the past 5 years. The most-recent trade in Eli Lilly and Co is the sale of 25,000 shares on February 15, 2019, which brought Enrique A Conterno around $3 Million.
According to the SEC Form 4 filings, Enrique A Conterno has made a total of 8 transactions in FibroGen Inc (FGEN) over the past 5 years, including 1 buys and 7 sells. The most-recent trade in FibroGen Inc is the sale of 1,880 shares on July 7, 2023, which brought Enrique A Conterno around $5,264.
Insider Trading History of Enrique A Conterno
- 1
Enrique A Conterno Trading Performance
GuruFocus tracks the stock performance after each of Enrique A Conterno's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Enrique A Conterno is 20.49%. GuruFocus also compares Enrique A Conterno's trading performance to market benchmark return within the same time period. The performance of stocks bought by Enrique A Conterno within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Enrique A Conterno's insider trading performs compared to the benchmark.
Performance of Enrique A Conterno
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.34 | 20.49 | 17.17 | -25.54 | -48.31 | -21.46 |
| Relative Return to S&P 500(%) | 13.25 | 9.2 | -4.86 | -67.02 | -62.32 | -34.2 |
Enrique A Conterno Ownership Network
Ownership Network List of Enrique A Conterno
Ownership Network Relation of Enrique A Conterno
Enrique A Conterno Owned Company Details
What does FibroGen Inc do?
Who are the key executives at FibroGen Inc?
Enrique A Conterno is the director & Chief Executive Officer of FibroGen Inc. Other key executives at FibroGen Inc include Chief Commercial Officer Thane Wettig , SVP & China Operations Christine Chung , and Chief Financial Officer Juan Graham .
FibroGen Inc (FGEN) Insider Trades Summary
Over the past 18 months, Enrique A Conterno made 7 insider transaction in FibroGen Inc (FGEN) with a net sale of 92,477. Other recent insider transactions involving FibroGen Inc (FGEN) include a net purchase of 29,738 shares made by Thane Wettig , a net sale of 39,779 shares made by Christine Chung , and a net sale of 19,563 shares made by Juan Graham .
In summary, during the past 3 months, insiders sold 0 shares of FibroGen Inc (FGEN) in total and bought 50,000 shares, with a net purchase of 50,000 shares. During the past 18 months, 255,701 shares of FibroGen Inc (FGEN) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 205,701 shares.
FibroGen Inc (FGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
FibroGen Inc Insider Transactions
Enrique A Conterno Mailing Address
Above is the net worth, insider trading, and ownership report for Enrique A Conterno. You might contact Enrique A Conterno via mailing address: Lilly Corporate Center, Indianapolis In 46285.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
